Excellent
Fully Aligned
Patient Risk:
High
Summary
The evaluated claim is directly supported by the provided FDA label excerpts, including the warning/precaution language and the adverse reaction listing.
Category Scores
Accurate Statements
Using MARCAINE (bupivacaine) in obstetrical anesthesia is associated with risk of cardiac arrest (including difficult-to-resuscitate or fatal events).
Supported by label section 5.1 (reports of cardiac arrest with difficult resuscitation or death during use of MARCAINE for epidural anesthesia in obstetrical patients) and section 6 (clinically significant adverse reaction: Cardiac Arrest in Obstetrical Anesthesia, cross-referenced to 5.1).
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
High
The claim concerns a serious labeled risk (cardiac arrest with difficult resuscitation or death) associated with obstetrical epidural anesthesia use of MARCAINE, as described in the provided label excerpts.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement